title: Verocytotoxin-producing Escherichia coli infection in hemolytic uremic syndrome in part of western Europe.
abstract: From September 1989 until September 1993, stool specimens and sera from 113 children with diarrhoea-associated haemolytic uraemic syndrome (HUS) from the Netherlands, two university hospitals in Belgium and one university hospital in Germany were examined for the presence of verocytotoxin-producing Escherichia coli (VTEC) infection. Evidence for VTEC infection was observed in 88 (78%) patients with HUS compared to 2 (3%) of the 65 children with acute gastro-enteritis Serotype O157 was the causative agent in 76 (86%) of these 88 patients with VTEC-associated HUS and verocytotoxin-2 (VT-2) was the most frequent toxin produced. Serological testing for antibodies to O157 O-antigen yielded the highest number of positive results compared to the other test methods. Antibodies to O157 were found in sera of 71 (65%) of 110 patients with HUS and one control serum. Stool and sera examination for VTEC in 95 family contacts of 28 patients with HUS demonstrated an evidence for VTEC infection 33 (35%). In contrast, in patients with HUS serological antibodies to O157 O-antigen were found in only 3 (4%) of 85 family contacts.
  
  
  CONCLUSIONS
  In this part of Western Europe, VT2-producing Escherichia coli, mainly those belonging to serogroup O157, are the major cause of HUS in childhood.
authors.affiliation: Department of Paediatrics, University Hospital, Nijmegen, The Netherlands.
authors.forename: N C
authors.initials: NC
authors.lastname: van de Kar
authors.forename: H G
authors.initials: HG
authors.lastname: Roelofs
authors.forename: H L
authors.initials: HL
authors.lastname: Muytjens
authors.forename: J J
authors.initials: JJ
authors.lastname: Tolboom
authors.forename: B
authors.initials: B
authors.lastname: Roth
authors.forename: W
authors.initials: W
authors.lastname: Proesmans
authors.forename: W C
authors.initials: WC
authors.lastname: Reitsma-Bierens
authors.forename: E D
authors.initials: ED
authors.lastname: Wolff
authors.forename: M A
authors.initials: MA
authors.lastname: Karmali
authors.forename: H
authors.initials: H
authors.lastname: Chart
authors.forename: L A
authors.initials: LA
authors.lastname: Monnens
mesh_terms: D001427:Bacterial Toxins / Q000145:classification*; D001530:Belgium / Q000453:epidemiology; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D004927:Escherichia coli Infections / Q000150:complications* / Q000382:microbiology; D005260:Female; D005759:Gastroenteritis / Q000150:complications* / Q000382:microbiology; D005858:Germany / Q000453:epidemiology; D006463:Hemolytic-Uremic Syndrome / Q000453:epidemiology*; D006801:Humans; D007223:Infant; D008297:Male; D009426:Netherlands / Q000453:epidemiology; D011446:Prospective Studies; D012703:Serotyping
chemical_list: D001427:Bacterial Toxins